Douglas A. Melton
Fondateur chez Semma Therapeutics, Inc.
Profil
Douglas A.
Melton is the founder of Semma Therapeutics, Inc. founded in 2015 where he holds the title of Director.
He is also the founder of Gilead Sciences, Inc., Curis, Inc. Dr. Melton's current jobs include being a Professor at Harvard University, Co-Chair at Harvard Stem Cell Institute, and Partner and Advisor at JDRF T1D Fund.
His former jobs include being an Independent Director at bluebird bio, Inc. from 2017 to 2020 and a Trustee at The Marine Biological Laboratory.
Dr. Melton's education history includes an undergraduate degree from the University of Cambridge and the University of Illinois, and a doctorate degree from Trinity College & University.
Postes actifs de Douglas A. Melton
| Sociétés | Poste | Début |
|---|---|---|
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Fondateur | 01/01/2015 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Harvard Stem Cell Institute
 Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Président | - |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
Anciens postes connus de Douglas A. Melton
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEBIRD BIO, INC. | Directeur/Membre du Conseil | 30/09/2020 |
| CURIS, INC. | Fondateur | 06/06/2007 |
| GILEAD SCIENCES, INC. | Fondateur | - |
The Marine Biological Laboratory
 The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Directeur/Membre du Conseil | - |
Formation de Douglas A. Melton
| University of Illinois | Undergraduate Degree |
| University of Cambridge | Undergraduate Degree |
| Trinity College & University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CURIS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA. | Commercial Services |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Harvard Stem Cell Institute
Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Health Technology |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |